Related Experiment Videos
[Method of measuring non-protein bound fucose]
Klinicheskaia Laboratornaia Diagnostika
|April 1, 1997
Summary
A new method measures serum fucose, an enzyme that increases with age. Elevated levels are linked to myeloma, liver cirrhosis, rheumatic fever, osteomyelitis, and gastroduodenitis.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Medical Diagnostics
Background:
- Fucose, a monosaccharide, plays roles in biological processes.
- Measuring free fucose in serum can offer insights into various physiological and pathological states.
- Existing methods may not accurately quantify non-protein-bound fucose.
Purpose of the Study:
- To develop and validate a novel method for quantifying serum fucose not bound to proteins.
- To investigate the correlation between serum free fucose levels and age.
- To assess the diagnostic potential of serum free fucose in specific diseases.
Main Methods:
- Development of a specific assay for measuring free fucose in human serum.
- Validation of the assay's accuracy, precision, and sensitivity.
- Analysis of serum samples from healthy individuals across different age groups and patients with specific conditions.
Main Results:
- A reliable method for measuring serum non-protein-bound fucose was established.
- Serum free fucose levels demonstrated a positive correlation with increasing age.
- Significantly elevated serum free fucose levels were observed in adult patients with myeloma, liver cirrhosis, and rheumatic fever.
- Increased levels were also noted in children experiencing exacerbations of chronic osteomyelitis and gastroduodenitis.
Conclusions:
- The developed method provides a valuable tool for assessing serum free fucose.
- Age is a significant factor influencing serum free fucose concentrations.
- Serum free fucose may serve as a potential biomarker for inflammatory and neoplastic conditions, including myeloma, liver cirrhosis, rheumatic fever, osteomyelitis, and gastroduodenitis.